NDC 60512-6435

ABELMOSCHUS

Abelmoschus

ABELMOSCHUS is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Homeolab Usa Inc. The primary component is Abelmoschus Moschatus Seed.

Product ID60512-6435_45084b0d-210b-4fc5-afa7-2f83fb28924e
NDC60512-6435
Product TypeHuman Otc Drug
Proprietary NameABELMOSCHUS
Generic NameAbelmoschus
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2013-11-14
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHOMEOLAB USA INC
Substance NameABELMOSCHUS MOSCHATUS SEED
Active Ingredient Strength6 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 60512-6435-1

80 PELLET in 1 TUBE (60512-6435-1)
Marketing Start Date2013-11-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60512-6435-1 [60512643501]

ABELMOSCHUS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-11-14
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ABELMOSCHUS MOSCHATUS SEED6 [hp_X]/1

OpenFDA Data

SPL SET ID:534ed9f1-2763-4fd5-8ba9-0cd7e1aa5e5d
Manufacturer
UNII

NDC Crossover Matching brand name "ABELMOSCHUS" or generic name "Abelmoschus"

NDCBrand NameGeneric Name
0220-0002ABELMOSCHUSABELMOSCHUS MOSCHATUS SEED
60512-6435ABELMOSCHUSABELMOSCHUS
68428-000AbelmoschusABELMOSCHUS MOSCHATUS SEED
68428-170AbelmoschusABELMOSCHUS MOSCHATUS SEED

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.